Imunon, Inc.

IMNN

Imunon, Inc.

IMNN

Insider Sentiment (TTM):

Last Purchase:2024-08-20Last Sale:2026-06-29Shares Purchased (TTM):0Shares Sold (TTM):11,800

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:491,566Shares Outstanding:5,028,764Institutional Ownership Pct.:9.78%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	7	5	9	5	5	3	6	10	5	2	6	13
Available For Sale Securities Debt Securities Curr…	-	-	-	-	-	-	-	-	-	7	10	6
Debt Securities Held To Maturity Accrued Interest …	-	-	-	-	-	-	-	-	-	-	-	0
Grants Receivable Current	2	2	2	2	2	2	2	2	2	2	3	2
Assets Current	9	7	11	7	7	5	8	13	8	12	18	22
Property Plant And Equipment Net	0	0	1	1	1	1	1	1	1	1	1	1
Other Assets
Deferred Income Tax Assets Net	-	-	-	-	-	-	-	-	-	-	1	-
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	1	1	1	2	2
Deposits Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	6	1	1	1	1	1	1	1	1	2	3	2
Assets	15	8	12	9	9	7	10	14	10	14	22	25
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Trade Current	2	1	1	1	2	2	1	2	2	2	4	2
Accrued Liabilities Current	1	3	3	3	3	4	3	3	3	2	3	3
Operating Lease Liability Current	0	0	0	0	0	0	0	1	1	1	0	0
Liabilities Current	5	4	5	4	5	6	5	5	5	5	7	5
Operating Lease Liability Noncurrent	0	0	1	1	1	1	1	1	1	1	1	1
Liabilities	11	5	5	5	6	6	5	6	6	6	9	7
Stockholders Equity
Preferred Stock Value	0	-	-	-	-	-	-	-	-	-	-	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	-	429	428	421	416	411	411	411	402	401	402	401
Retained Earnings Accumulated Deficit	-428	-426	-421	-417	-414	-411	-407	-403	-398	-393	-388	-383
Stockholders Equity Before Treasury Stock	4	3	7	4	3	1	4	8	4	9	13	18
Treasury Stock Value	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Accumulated Other Comprehensive Income Loss Net Of…	-	-	0	-	-	-	0	-	-	0	0	0
Stockholders Equity	4	3	7	4	3	0	4	8	4	8	13	18
Liabilities And Stockholders Equity	15	8	12	9	9	7	10	14	10	14	22	25
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	350	350	350	350	113	113	113	113	113	113	113	113
Common Stock Shares Issued	5	4	3	3	2	1	1	1	1	1	1	1
Shares Outstanding	5	4	3	3	32	1	1	1	1	1	1	1
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-23.70%	-29.26%	-41.11%	-	-	-	-	-	-	-	-	-
2025	78.05%	-3.66%	-30.89%	-22.15%	-32.00%	-36.33%	-6.25%	-5.05%	-20.19%	-5.10%	-25.17%	-38.10%
2024	-14.19%	-8.11%	-23.65%	8.33%	12.50%	-1.04%	2.44%	-3.66%	17.07%	17.28%	9.88%	-40.74%
2023	-	-	-	-	-	-	-11.58%	-27.37%	-42.11%	-28.66%	-14.63%	-31.71%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.82	1.59	2.32	1.73	1.30	0.88	1.67	2.30	1.51	2.51	2.47	4.09
Quick Ratio	1.82	1.59	2.32	1.73	1.30	0.88	1.67	2.30	1.51	2.51	2.47	4.09
Working Capital	3.91M	2.45M	6.10M	3.06M	1.57M	-704.93K	3.22M	7.09M	2.57M	7.28M	10.85M	16.41M
Leverage & Debt
Debt to Equity	2.58	1.39	0.74	1.20	2.30	14.18	1.29	0.76	1.59	0.69	0.64	0.36
Interest Coverage TTM	-	-	-	-	-	-	-	-106.32	-50.48	-47.21	-35.57	-4.24
Debt Ratio	0.72	0.58	0.43	0.55	0.70	0.93	0.56	0.43	0.61	0.41	0.39	0.27
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-2.81	-2.91	-6.83	-4.87	-12.33	-13.68	-16.94	-15.08	-28.85	-30.07	-32.35	-44.54
Free Cash Flow Per Share TTM	-2.90	-2.99	-6.68	-5.08	-11.41	-12.38	-17.18	-14.13	-30.12	-34.00	-32.28	-33.18
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-	-	-	-	-	-17,591.64%
Net Profit Margin TTM	-	-	-	-	-	-	-	-	-	-	-	-22,287.62%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%	-75.00%
Net Income Growth (1Y)	-6.55%	-17.71%	-22.15%	-26.33%	-12.92%	-5.62%	-4.58%	-30.18%	-40.77%	-39.21%	-45.64%	3.62%
EPS Growth (1Y)	-77.19%	-78.71%	-59.71%	-67.72%	-57.27%	-54.52%	-47.61%	-66.14%	-42.41%	-46.45%	-57.07%	-21.56%
Valuation Metrics
P/E TTM	-0.63	-1.01	-0.56	-1.05	-0.85	-1.00	-0.73	-0.92	-0.52	-0.71	-0.27	-0.29
P/B TTM	2.22	4.40	1.15	3.70	5.01	39.42	3.21	2.18	2.53	1.58	0.40	0.44
P/S TTM	-	-	-	-	-	-	-	-	-	-	-	63.96
Market Cap	9.31M	14.78M	8.09M	15.10M	13.33M	17.82M	13.62M	17.83M	9.48M	13.41M	5.35M	7.99M
Enterprise Value	2.45M	9.99M	-691.12K	9.85M	8.60M	14.95M	7.74M	7.52M	4.18M	11.06M	-487.36K	-4.89M
Calculated Values
Free Cash Flow TTM	-15.18M	-15.06M	-14.18M	-14.95M	-14.57M	-16.11M	-18.88M	-18.22M	-18.88M	-21.32M	-19.47M	-20.75M
Net Debt	-6.86M	-4.79M	-8.78M	-5.25M	-4.73M	-2.87M	-5.87M	-10.31M	-5.31M	-2.35M	-5.84M	-12.88M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-29Sale

Owner: Eylward, Susan

Title: General Counsel and Corp Sec

Shares: 11,800

Price/Share: $1.75

Value: $20,650.00

Shares Owned: 2,896

Relationship: Officer

Ownership: Direct

2024-08-20Purchase

Owner: Braun, Donald P

Title: -

Shares: 25,000

Price/Share: $1.18

Value: $29,500.00

Shares Owned: 25,597

Relationship: Director

Ownership: Direct

2024-08-15Purchase

Owner: Lindborg, Stacy

Title: President and CEO

Shares: 25,000

Price/Share: $0.98

Value: $24,500.00

Shares Owned: 264,166

Relationship: Director,Officer

Ownership: Direct

2024-08-15Purchase

Owner: Tardugno, Michael H

Title: Executive Chairman of Board

Shares: 25,000

Price/Share: $1.03

Value: $25,750.00

Shares Owned: 353,346

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-29	Eylward, Susan	Officer	General Counsel and Corp Sec	Direct	Sale	11,800	1.75	$20,650.00	2,896	4
2024-08-20	Braun, Donald P	Director	-	Direct	Purchase	25,000	1.18	$29,500.00	25,597	4
2024-08-15	Lindborg, Stacy	Director,Officer	President and CEO	Direct	Purchase	25,000	0.98	$24,500.00	264,166	4
2024-08-15	Tardugno, Michael H	Director,Officer	Executive Chairman of Board	Direct	Purchase	25,000	1.03	$25,750.00	353,346	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

9.78%

Inst. Shares: 491,566

Shares Outstanding: 5,028,764

2025-12-31

20.34%

Inst. Shares: 431,938

Shares Outstanding: 2,123,344

2025-09-30

5.35%

Inst. Shares: 157,399

Shares Outstanding: 2,943,655

2025-06-30

168.72%

Inst. Shares: 2,154,981

Shares Outstanding: 1,277,217

2025-03-31

26.35%

Inst. Shares: 342,758

Shares Outstanding: 1,300,944

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	491,566	5,028,764	9.78%
2025-12-31	431,938	2,123,344	20.34%
2025-09-30	157,399	2,943,655	5.35%
2025-06-30	2,154,981	1,277,217	168.72%
2025-03-31	342,758	1,300,944	26.35%
2024-12-31	405,875	1,098,899	36.93%
2024-09-30	1,000,800	1,289,823	77.59%
2024-06-30	337,931	626,726	53.92%
2024-03-31	194,850	626,969	31.08%
2023-12-31	273,452	603,323	45.32%
2023-09-30	327,575	625,437	52.38%
2023-06-30	325,700	609,409	53.45%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Imunon, Inc. (IMNN) — SEC Financial Statements & Analysis

Imunon, Inc. (IMNN) is a pharmaceutical preparations company, incorporated in DE. Imunon, Inc. trades on Nasdaq as: IMNN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Imunon, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 2.58x, a Price-to-Sales (P/S) ratio of 63.96x (TTM), a Price-to-Book (P/B) ratio of 2.22x (TTM), at a market cap of $9.31M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 2.58x
P/S TTM: 63.96x
P/B TTM: 2.22x
Market Cap: $9.31M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Imunon, Inc. in?

Imunon, Inc. (IMNN) operates in the Pharmaceutical Preparations industry.

What is IMNN's market cap?

Imunon, Inc. (IMNN) has a market capitalization of $9.31M as of 2026-06-30.

What exchange does IMNN trade on?

Imunon, Inc. (IMNN) trades on the Nasdaq.

Where is Imunon, Inc. incorporated?

Imunon, Inc. is incorporated in DE.

Imunon, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Imunon, Inc. (IMNN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Imunon, Inc. (IMNN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.